EDWARD MASON to Pneumococcal Infections
This is a "connection" page, showing publications EDWARD MASON has written about Pneumococcal Infections.
Connection Strength
5.246
-
Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol. 2011 Jun; 49(6):2097-101.
Score: 0.301
-
Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010 Mar; 125(3):429-36.
Score: 0.279
-
Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol. 2010 Feb; 48(2):520-5.
Score: 0.275
-
Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007 Jun; 26(6):480-4.
Score: 0.231
-
Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006 Mar; 25(3):250-4.
Score: 0.212
-
Penicillin resistance and serotypes/serogroups of Streptococcus pneumoniae in nasopharyngeal carrier children younger than 2 years in Lima, Peru. Diagn Microbiol Infect Dis. 2005 May; 52(1):59-64.
Score: 0.200
-
Impact of the conjugate pneumococcal vaccine in arkansas. Pediatr Infect Dis J. 2004 Dec; 23(12):1125-9.
Score: 0.194
-
Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine. Pediatrics. 2003 Apr; 111(4 Pt 1):896-9.
Score: 0.173
-
Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002. Pediatr Ann. 2002 Apr; 31(4):250-60.
Score: 0.161
-
Pneumococcal mastoiditis in children. Pediatrics. 2000 Oct; 106(4):695-9.
Score: 0.146
-
Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis. J Antimicrob Chemother. 2000 May; 45(5):623-31.
Score: 0.141
-
Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev. 1998 Oct; 11(4):628-44.
Score: 0.127
-
Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):249-252.
Score: 0.126
-
Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post-Pneumococcal Conjugate Vaccine Era. Pediatr Infect Dis J. 2017 Dec; 36(12):1201-1204.
Score: 0.120
-
Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clin Infect Dis. 2017 Jun 15; 64(12):1699-1704.
Score: 0.116
-
Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era. Transpl Infect Dis. 2017 Feb; 19(1).
Score: 0.112
-
Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States. J Clin Microbiol. 2017 03; 55(3):724-734.
Score: 0.111
-
Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics. Clin Infect Dis. 2016 Sep 01; 63(5):619-626.
Score: 0.108
-
Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children. Vaccine. 2016 Jan 20; 34(4):474-478.
Score: 0.104
-
Penicillin-resistant pneumococci in the United States. Pediatr Infect Dis J. 1995 Nov; 14(11):1017-8.
Score: 0.103
-
Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2015 May 01; 60(9):1339-45.
Score: 0.098
-
Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J. 2014 Oct; 33(10):1033-6.
Score: 0.096
-
Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7. Pediatrics. 2013 Jul; 132(1):e17-24.
Score: 0.088
-
Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013 Mar; 32(3):203-7.
Score: 0.086
-
Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol. 2013 Apr; 51(4):1294-7.
Score: 0.086
-
Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother. 1992 Aug; 36(8):1703-7.
Score: 0.083
-
The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J. 2012 Mar; 31(3):228-34.
Score: 0.080
-
Characterization of nontypeable and atypical Streptococcus pneumoniae pediatric isolates from 1994 to 2010. J Clin Microbiol. 2012 Apr; 50(4):1326-30.
Score: 0.079
-
Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine. 2011 Nov 15; 29(49):9123-6.
Score: 0.078
-
Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J. 2010 Aug; 29(8):712-6.
Score: 0.072
-
Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis. Pediatr Infect Dis J. 2009 Sep; 28(9):766-8.
Score: 0.068
-
Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J. 2006 Apr; 25(4):301-5.
Score: 0.053
-
Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens. Vaccine. 2006 Mar 24; 24(14):2514-20.
Score: 0.052
-
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis. 2005 Jul 01; 41(1):21-9.
Score: 0.050
-
Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005 Jun 15; 40(12):1738-44.
Score: 0.050
-
Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. Pediatr Infect Dis J. 2004 May; 23(5):399-405.
Score: 0.047
-
Pneumococcal endocarditis in children. Clin Infect Dis. 2004 May 01; 38(9):1273-8.
Score: 0.046
-
Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004 Mar; 113(3 Pt 1):443-9.
Score: 0.046
-
Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis. 2003 Dec 01; 188(11):1679-84.
Score: 0.045
-
Streptococcus pneumoniae infections in the neonate. Pediatrics. 2003 Nov; 112(5):1095-102.
Score: 0.045
-
Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr Infect Dis J. 2003 Jul; 22(7):623-7.
Score: 0.044
-
Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J. 2002 Nov; 21(11):1008-16.
Score: 0.042
-
Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J. 2002 Apr; 21(4):278-82.
Score: 0.040
-
Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J. 2002 Feb; 21(2):141-7.
Score: 0.040
-
Invasive pneumococcal infections in pediatric cardiac transplant patients. Pediatr Infect Dis J. 2001 Oct; 20(10):946-50.
Score: 0.039
-
Pneumococcal infections in children after transplantation. Clin Infect Dis. 2001 Jul 01; 33(1):16-21.
Score: 0.038
-
Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J. 2001 Apr; 20(4):392-6.
Score: 0.038
-
Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J. 2001 Jan; 20(1):34-9.
Score: 0.037
-
Pneumococcal facial cellulitis in children. Pediatrics. 2000 Nov; 106(5):E61.
Score: 0.037
-
In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae. Int J Antimicrob Agents. 1999 Jul; 12(2):141-4.
Score: 0.033
-
Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics. 1998 Sep; 102(3 Pt 1):538-45.
Score: 0.031
-
Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage. Emerg Infect Dis. 2018 02; 24(2):405.
Score: 0.030
-
Discrepancies between results by E-test and standard microbroth dilution testing of Streptococcus pneumoniae for susceptibility to vancomycin. J Clin Microbiol. 1996 Jun; 34(6):1546-7.
Score: 0.027
-
Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993 Dec; 92(6):761-7.
Score: 0.023
-
Factors associated with middle ear isolates of Streptococcus pneumoniae resistant to penicillin in a children's hospital. J Pediatr. 1991 Dec; 119(6):941-4.
Score: 0.020
-
Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics. 2008 Jul; 122(1):34-9.
Score: 0.016
-
Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine. 2001 Dec 12; 20(5-6):826-37.
Score: 0.010
-
Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother. 1995 May; 39(5):1166-8.
Score: 0.006
-
Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J Clin Microbiol. 1994 Feb; 32(2):430-2.
Score: 0.006